Page-2 of Pharmaceuticals Sector Current Affairs, GK & News
GoI halts online drug sales
The Government of India has halted online sales of drugs as it is working on framing rules to regulate the sector. This has hit the pharmacy sector greatly. Delhi High Court’s Order The order of sale prohibition was initiated by the Drugs Controller General of India (DCGI) V.G.Somani. The order has referred to the Delhi ..
Month: Current Affairs - December, 2019
Category: Legal & Constitution Current Affairs
Topics: CLAT • Delhi High Court • DPIIT • Drugs and Cosmetics Act 1940 • E-commerce • e-commerce platform • e-commerce policy • Information Technology Act • Pharmaceuticals • Pharmaceuticals Sector
Cipla acquires two US generic drug companies
Indian pharmaceutical giant Cipla Ltd. has acquired two US generic drug companies, InvaGen Pharmaceuticals Inc. and Exelan Pharmaceuticals Inc. In this regard, Cipla has closed the transaction of the deal through its wholly-owned subsidiary, Cipla (EU) Ltd. Key facts These deals will allow Cipla to further strengthen its presence in the US pharmaceutical market is ..
Month: Current Affairs - February, 2016
Topics: Business • Cipla • Current Affairs 2016 • Economy • Pharmaceuticals Sector • United States
WHO accords PQP certification to Indian vaccine maker GreenSignal Bio Pharma
The World Health Organisation (WHO), a UN Health agency has accorded PQP (Pre-qualification of Medicines Programme) certification to Chennai based GreenSignal Bio Pharma. The Indian pharmaceutical company was accorded this certification for manufacturing a BCG (Bacillus Calmette–Guérin) vaccine. With this, it became second Indian company to get PQP certification from WHO. What is PQP certification? ..
Month: Current Affairs - February, 2016
Topics: Business • Current Affairs 2016 • Economy • Pharmaceuticals Sector • WHO
Mallinckrodt Pharma acquires Therakos for USD 1.3 billion from Gores Group
Mallinckrodt, a leader in biopharmaceutical has signed an agreement to buy a leading immunotherapy company Therakos Inc, from the global investment firm, Gores Group for approximately 1.325 billion US dollars. Significance of Therakos Acquisition: Therakos Inc is a US based global leader in autologous immune cell therapy delivered through extracorporeal photopheresis (ECP) that focuses to harness the power of ..
Month: Current Affairs - August, 2015
Topics: Acquisition • Business • Pharmaceuticals Sector